Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review

被引：4

作者：

Rao, Karthik Nagaraja ^{[1
]}

Randolph, Gregory W. ^{[2
]}

Lopez, Fernando ^{[3
]}

Zafereo, Mark ^{[4
]}

Coca-Pelaz, Andres ^{[3
]}

Piazza, Cesare ^{[5
]}

Dange, Prajwal ^{[1
]}

Rodrigo, Juan Pablo ^{[3
]}

Stenman, Goeran ^{[6
]}

de Keizer, Bart ^{[7
]}

Nixon, Iain ^{[8
]}

Sinha, Shriyash ^{[1
]}

Leboulleux, Sophie ^{[9
]}

Maekitie, Antti A. ^{[10
,11
]}

Agaimy, Abbas ^{[12
,13
]}

Thompson, Lester ^{[14
]}

Ferlito, Alfio ^{[15
]}

机构：

[1] Sri Shankara Canc Hosp & Res Ctr, Dept Head & Neck Surg Oncol, Bangalore 560004, Karnataka, India

[2] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Otolaryngol Head & Neck Surg, Div Thyroid & Parathyroid Endocrine Surg, Boston, MA USA

[3] Univ Oviedo, Hosp Univ Cent Asturias, Dept Otolaryngol, CIBERONC,ISPA,IUOPA, Oviedo 33011, Spain

[4] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX USA

[5] ASST Spedali Civili Brescia, Unit Otorhinolaryngol Head & Neck Surg, Brescia, Italy

[6] Univ Gothenburg, Sahlgrenska Ctr Canc Res, Dept Pathol, Gothenburg, Sweden

[7] Univ Med Ctr Utrecht, Dept Nucl Med & Radiol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands

[8] Univ Edinburgh, Dept Surg & Otolaryngol Head & Neck Surg, Edinburgh EH3 9YL, Scotland

[9] Univ Geneva, Geneva Univ Hosp, Dept Endocrinol Diabetol Nutr & Therapeut Educ, Rue Gabrielle Perret Gentil, Geneva, Switzerland

[10] Univ Helsinki, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland

[11] Univ Helsinki, Res Program Syst Oncol, Helsinki, Finland

[12] Friedrich Alexander Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, D-91054 Erlangen, Germany

[13] Comprehens Canc Ctr Erlangen EMN CCC ER EMN, D-91054 Erlangen, Germany

[14] Head & Neck Pathol Consultat, Woodland Hills, CA 91364 USA

[15] Coordinator Int Head & Neck Sci Grp, Padua, Italy

来源：

ENDOCRINE | 2024年 / 85卷 / 02期

关键词：

Thyroid neoplasms; Risk assessment; Molecular testing; Bethesda system; Artificial intelligence; PERFORMANCE; PREDICTOR; CANCER;

D O I：

10.1007/s12020-024-03737-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The increasing prevalence of thyroid cancer emphasizes the need for a thorough assessment of risk of malignancy in Bethesda III nodules. Various methods ranging commercial platforms of molecular genetic testing (including Afirma (R) GEC, Afirma (R) GSC, ThyroSeq (R) V3, RosettaGX (R), ThyGeNEXT (R)/ThyraMIR (R), ThyroidPRINT (R)) to radionuclide scans and ultrasonography have been investigated to provide a more nuanced comprehension of risk estimation. The integration of molecular studies and imaging techniques into clinical practice may provide clinicians with improved and personalized risk assessment. This integrated approach we feel may enable clinicians to carefully tailor interventions, thereby minimizing the likelihood of unnecessary thyroid surgeries and overall crafting the optimal treatment. By aligning with the evolving landscape of personalized healthcare, this comprehensive strategy ensures a patient-centric approach to thyroid nodule and thyroid cancer management.

引用

页码：473 / 492

页数：20

共 76 条

[1] PET/CT May Assist in Avoiding Pointless Thyroidectomy in Indeterminate Thyroid Nodules: A Narrative Review
Abou Karam, Gaby
Malhotra, Ajay
[J]. CANCERS, 2023, 15 (05)
[2] Preoperative Thyroid-Stimulating Hormone Levels and Risk of Thyroid Cancer in Post-thyroidectomy Patients for Thyroid Nodules: A Study From a Tertiary Hospital in Western Saudi Arabia
Al-Hakami, Hadi Afandi
Altayyeb, Jamelah F.
Alsharif, Salwan M.
Alshareef, Mohammad A.
Awad, Baraa I.
Al-Garni, Mohammed
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
[3] Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
Alexander, Erik K.
Kennedy, Giulia C.
Baloch, Zubair W.
Cibas, Edmund S.
Chudova, Darya
Diggans, James
Friedman, Lyssa
Kloos, Richard T.
LiVolsi, Virginia A.
Mandel, Susan J.
Raab, Stephen S.
Rosai, Juan
Steward, David L.
Walsh, P. Sean
Wilde, Jonathan I.
Zeiger, Martha A.
Lanman, Richard B.
Haugen, Bryan R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (08) : 705 - 715
[4] Ali SZ, 2023, THYROID, V33, P1039, DOI [10.1016/j.jasc.2023.05.005, 10.1089/thy.2023.0141]
[5] Serum TSH as a predictor of malignancy in indeterminate thyroid nodules
Amado, A.
Castro, B.
Torre, A. P.
Graca, S.
Tavares, A.
Povoa, A.
Soares, C.
Goncalves, G.
[J]. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2022, 104 (05) : 380 - 384
[6] Unraveling the significance of TSHR mutations in indeterminate thyroid cytology specimens
Andrianus, Stefen
Gubbiotti, Maria A.
Mandel, Susan J.
Nikiforov, Yuri E.
Baloch, Zubair
[J]. DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (07) : 406 - 413
[7] [Anonymous], F MOL TESTING PDF 11
[8] Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications
Babajani, Amirhesam
Rahmani, Saeed
Raoufi, Masoomeh
Eidgahi, Elham Shaarbaf
Dastjerdi, Amirreza Vahid
Behfarnia, Poya
Khalili, Shayesteh
Moghaddam, Noushin Afshar
[J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[9] SANRA-a scale for the quality assessment of narrative review articles
Baethge, Christopher
Goldbeck-Wood, Sandra
Mertens, Stephan
[J]. RESEARCH INTEGRITY AND PEER REVIEW, 2019, 4 (01)
[10] Evaluation of 167 Gene Expression Classifier (GEC) and ThyroSeq v2 Diagnostic Accuracy in the Preoperative Assessment of Indeterminate Thyroid Nodules: Bivariate/HROC Meta-analysis
Borowczyk, Martyna
Szczepanek-Parulska, Ewelina
Olejarz, Michal
Wieckowska, Barbara
Verburg, Frederik A.
Debicki, Szymon
Budny, Bartlomiej
Janicka-Jedynska, Malgorzata
Ziemnicka, Katarzyna
Ruchala, Marek
[J]. ENDOCRINE PATHOLOGY, 2019, 30 (01) : 8 - 15

← 1 2 3 4 5 6 7 8 →